Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Jiangsu Recbio Technology Co., Ltd. Class H ( (HK:2179) ) has provided an announcement.
Jiangsu Recbio Technology Co., Ltd. held its Annual General Meeting on June 20, 2025, where all proposed resolutions were passed. These resolutions included approvals of financial reports, work reports, and the appointment of a board observer, as well as amendments to the Articles of Association. The successful passage of these resolutions indicates strong shareholder support and positions the company for continued strategic development and operational enhancements.
More about Jiangsu Recbio Technology Co., Ltd. Class H
Jiangsu Recbio Technology Co., Ltd. is a joint stock company incorporated in China, operating in the biotechnology industry. The company focuses on the development and commercialization of innovative vaccines and related products, aiming to address global health challenges.
Average Trading Volume: 66,775
Technical Sentiment Signal: Sell
Current Market Cap: HK$4.07B
See more data about 2179 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue